Staff Members - Benha University
Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response
• 2022
Publication Information
Authors
Hala A. Agina1, Nermine A. Ehsan2, Taghreed A. Abd-Elaziz1, Ghada A. Abd-Elfatah1, Eman M. Said1, Mostafa M. Sira
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Aim of the study: Autoimmune hepatitis (AIH) is characterized histologically by aggressive inflammation with
interface hepatitis and prominent lymphoplasmacytic infiltration. Programmed death-1 (PD-1) is expressed on
activated lymphocytes. Engagement of PD-1 by its ligand PD-L1 leads to cell apoptosis and death. We aimed
to evaluate the immunohistochemical expression of PD-1 and PD-L1 in children with AIH, and its relation to
treatment outcome.
Material and methods: Pre-treatment liver biopsies of 31 children with AIH were compared to 30 children with
chronic hepatitis C virus (HCV) infection as a control group. PD-1 was evaluated in lymphocytes, while PD-L1 was
evaluated in lymphocytes, hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells. All
AIH patients received the standard treatment.
Results: The mean PD-1 was significantly higher in AIH than HCV patients (29.19 ±18.5% vs. 15.2 ±10.1%;
p = 0.002) while there was no statistically significant difference as regards PD-L1 on lymphocytes (p = 0.853).
Neither PD-1 nor PD-L1 correlated with either liver fibrosis or the inflammatory activity (p > 0.05 for all). PD-1/
PD-L1 ratio was significantly higher in AIH compared to HCV patients and in non-responder AIH patients compared
to responders (46.9 vs. 6.58). PD-1 expression was comparable in both responders and non-responders
(p = 0.813), while PD-L1 was significantly upregulated in responders (4.17 ±3.15% vs. 0.63 ±1.3%; p = 0.046).
PD-L1 expression on hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells was comparable
in AIH and HCV groups.
Conclusions: PD-1/PD-L1 ratio, which reflects immune aggression, was significantly higher in AIH compared to
HCV patients and in non-responder AIH patients compared to responders.
interface hepatitis and prominent lymphoplasmacytic infiltration. Programmed death-1 (PD-1) is expressed on
activated lymphocytes. Engagement of PD-1 by its ligand PD-L1 leads to cell apoptosis and death. We aimed
to evaluate the immunohistochemical expression of PD-1 and PD-L1 in children with AIH, and its relation to
treatment outcome.
Material and methods: Pre-treatment liver biopsies of 31 children with AIH were compared to 30 children with
chronic hepatitis C virus (HCV) infection as a control group. PD-1 was evaluated in lymphocytes, while PD-L1 was
evaluated in lymphocytes, hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells. All
AIH patients received the standard treatment.
Results: The mean PD-1 was significantly higher in AIH than HCV patients (29.19 ±18.5% vs. 15.2 ±10.1%;
p = 0.002) while there was no statistically significant difference as regards PD-L1 on lymphocytes (p = 0.853).
Neither PD-1 nor PD-L1 correlated with either liver fibrosis or the inflammatory activity (p > 0.05 for all). PD-1/
PD-L1 ratio was significantly higher in AIH compared to HCV patients and in non-responder AIH patients compared
to responders (46.9 vs. 6.58). PD-1 expression was comparable in both responders and non-responders
(p = 0.813), while PD-L1 was significantly upregulated in responders (4.17 ±3.15% vs. 0.63 ±1.3%; p = 0.046).
PD-L1 expression on hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells was comparable
in AIH and HCV groups.
Conclusions: PD-1/PD-L1 ratio, which reflects immune aggression, was significantly higher in AIH compared to
HCV patients and in non-responder AIH patients compared to responders.